Irbesartan In Hypertensive Diabetic Patients.
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2011
At a glance
- Drugs Irbesartan; Irbesartan/hydrochlorothiazide
- Indications Diabetic nephropathies; Hypertension; Proteinuria
- Focus Therapeutic Use
- Acronyms I-PREVENT
- Sponsors Sanofi
- 01 Apr 2011 Actual patient numbers of 797 added
- 03 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2008 Planned end date changed from 1 Sep 2008 to 1 Oct 2008 as reported by ClinicalTrials.gov.